Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microglia cell membrane refers to the plasma membrane of microglia—brain-resident macrophages acting as the primary immune defense and maintenance cells in the central nervous system (CNS)[1][3][7]. It hosts a diverse set of **membrane proteins, pattern recognition receptors (PRRs), cytokine and chemokine receptors, ion channels, and transporters** essential for microglial activation, antigen recognition, synapse pruning, neuroinflammation, and phagocytosis[2][6]. The composition and function of these membrane proteins enable microglia to respond to infection, injury, and immune signals by transitioning into various functional phenotypes and by direct interaction with neurons and blood vessels[4]. The **membrane itself is not a single molecular target**, but houses many proteins that are considered therapeutic targets within specific disease contexts; examples include P2RY12, CX3CR1, and TREM2. Overall, the term "microglia cell membrane" is not a precise designation of a drug target, but an anatomical structure accommodating many critical targets implicated in CNS disease[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microglia cell membrane.